R G Stone Urological Research Institute

R.G. Stone Urological Research Institute is a specialised urology hospital located in Mumbai, Maharashtra, dedicated to the management of urological conditions with a strong emphasis on research and innovation in urological treatment. The institute is particularly known for its expertise in kidney stone disease (urolithiasis) management, which includes the full spectrum from medical dissolution through minimally invasive endourological procedures to open surgery.

The institute's research orientation sets it apart from routine urology hospitals. It actively investigates the epidemiology, pathophysiology, and optimal treatment of urolithiasis and other urological conditions prevalent in the Indian population, contributing to scientific literature and clinical protocol development.

Beyond kidney stones, the institute provides comprehensive urological services covering the prostate, bladder, kidneys, urinary tract, and male reproductive system. Endourology, laparoscopic urology, and open urological surgery are all available, enabling management from the simplest cystoscopic procedures to complex reconstructive and oncological urological surgeries.

Mumbai's position as a major medical centre and the institute's specialised reputation attracts referrals from across Maharashtra, other states, and internationally. Patients with complex recurrent stone disease, urological tumours, obstructive uropathy, and other challenging conditions seek the institute's expertise.

The combination of specialist urological focus and research activity makes R.G. Stone Urological Research Institute one of the distinctive urological institutions in western India, contributing to both patient care and the advancement of urological knowledge.

R.G. Stone Urological Research Institute provides comprehensive urological services covering all major subspecialty areas:

Urolithiasis (Kidney and Ureteral Stones): Complete stone management including ESWL (extracorporeal shock wave lithotripsy), ureteroscopy (URS) with laser lithotripsy, percutaneous nephrolithotomy (PCNL) for large kidney stones, retrograde intrarenal surgery (RIRS), and open surgery for complex cases.

Endourology: Cystoscopy, urethroscopy, bladder biopsy, ureteral stenting, JJ stenting, and all endoscopic urological procedures.

Prostate Disease: TURP (transurethral resection of the prostate) and laser prostatectomy (HoLEP, GreenLight) for BPH; prostate cancer diagnosis and management including prostatectomy.

Urological Oncology: Radical nephrectomy, partial nephrectomy for kidney tumours; radical cystectomy with urinary diversion for bladder cancer; radical prostatectomy.

Laparoscopic and Robotic Urology: Minimally invasive nephrectomy, pyeloplasty, adrenalectomy, and prostatectomy.

Reconstructive Urology: Urethroplasty for urethral stricture, pyeloplasty for PUJO, and bladder reconstructive procedures.

Female Urology: Stress urinary incontinence, overactive bladder, pelvic organ prolapse, and female urological conditions.

Paediatric Urology: Hypospadias repair, vesicoureteric reflux, undescended testes, and congenital urological abnormalities.

R.G. Stone Urological Research Institute is equipped with specialised urological technology and infrastructure for minimally invasive and open urological surgery.

The endourology suite houses video ureteroscopes, flexible ureterorenoscopes, and semirigid ureteroscopes with holmium laser lithotripsy systems for precise intracorporeal stone fragmentation. ESWL (extracorporeal shock wave lithotripsy) technology enables non-invasive stone fragmentation for eligible stones.

Percutaneous nephrolithotomy (PCNL) equipment including mini-PCNL and ultra-mini PCNL systems allows minimally invasive percutaneous kidney stone removal. Fluoroscopy and ultrasound guidance support safe percutaneous access. The cystoscopy suite handles outpatient bladder and urethral endoscopy, biopsies, and stenting.

Laparoscopic surgery towers with high-definition cameras and instruments support minimally invasive urological procedures including nephrectomy, pyeloplasty, and adrenalectomy. If robotic surgery is available, da Vinci system procedures can be performed for prostatectomy and complex reconstructive cases.

Operation theatres for open urological surgery manage complex reconstructive and oncological cases. Anaesthesia services support all procedures from spinal anaesthesia for endoscopy through general anaesthesia for major surgery.

The diagnostic urology section includes urodynamic testing (urinary flow rate, cystometry, urethral pressure profile) for lower urinary tract dysfunction assessment. Imaging support includes ultrasound, CT-KUB (for stone diagnosis), and IVP/urogram. The research laboratory supports metabolic stone workup and urine biochemistry analysis relevant to stone disease investigation.

R.G. Stone Urological Research Institute attracts international patients from across South Asia, the Middle East, and the global Indian diaspora who seek specialised urological care, particularly for complex kidney stone disease and urological tumour surgery.

Kidney stone treatment, prostate surgery, and urological oncology are among the most cost-effective procedures for international medical travel to India, with savings of 60-80% compared to equivalent treatment in Western countries while maintaining quality outcomes.

Patients from the UAE, Saudi Arabia, Bangladesh, Nepal, Sri Lanka, and East Africa seek the institute's expertise for minimally invasive stone procedures (PCNL, URS with laser), prostate laser surgery, and urological cancer surgery. The institute's research reputation provides additional assurance of clinical expertise for complex cases.

Administrative support for international patients includes pre-treatment medical record review, treatment planning consultations (including telemedicine preliminary consultations), visa support letter provision, and communication in English. Mumbai's international airport provides convenient access, and the hospital can coordinate airport transfers.

Discharge summaries, operative reports, and imaging in digital format are provided for all patients for continuity of care with home country urologists. Follow-up telemedicine consultations are available for stone recurrence monitoring and post-operative check-ups.

R.G. Stone Urological Research Institute operates under the Maharashtra Medical Council and Directorate of Health Services, Government of Maharashtra regulatory framework. The institute is registered and complies with applicable hospital regulations.

Urological procedures follow guidelines issued by the Urological Society of India (USI) and international guidelines from the European Association of Urology (EAU) and American Urological Association (AUA), particularly for stone management protocols (ESWL indications, URS vs PCNL selection, metabolic evaluation). The ESWL machine maintains manufacturer-recommended maintenance schedules.

The holmium laser system and other medical laser equipment follow AERB laser safety regulations. Surgical sterilisation and infection control follow national hospital infection prevention standards. The research wing follows ICMR ethical guidelines for clinical and laboratory studies.

Surgeons hold Maharashtra Medical Council registration and specialty qualifications in urology (MCh/DNB Urology). Membership in the Urological Society of India and active participation in urological academic conferences maintains clinical currency. Research publications in peer-reviewed journals are part of the institute's academic output.

Formal NABH accreditation or international certification status is pending verification by MyMedicPlus. The institute follows national healthcare standards appropriate to its specialist urological research hospital mission.